Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

NCT06135194 · clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing 302 Hospital